<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7453465\results\search\testTrace\results.xml">
  <result pre="pmcid: 7453465 doi: 10.1177/030006052094907710.1177_0300060520949077 : Review Understanding the epidemiology, pathophysiology," exact="diagnosis" post="and management of SARS-CoV-2 https://orcid.org/0000-0002-3952-2098FadakaAdewale Oluwaseun1https://orcid.org/0000-0001-7175-5388SibuyiNicole Remaliah Samantha1AdewaleOlusola Bolaji2BakareOlalekan"/>
  <result pre="syndrome coronavirus-2 (SARS-CoV-2). There is limited information on COVID-19, and" exact="treatment" post="has so far focused on supportive care and use"/>
  <result pre="precautionary measures to reduce the rate of disease spread include" exact="social distancing," post="good hygiene practices, and avoidance of crowded areas. These"/>
  <result pre="vaccines. In this review, we summarize the epidemiology, pathophysiology, and" exact="diagnosis" post="of COVID-19. We also address the mechanisms of action"/>
  <result pre="to practice good hygiene. Interestingly, countries with the highest reported" exact="prevalence" post="and mortality such as the United States, Spain, Italy,"/>
  <result pre="disease and belongs to lineage B of the beta-CoVs.11 SARS-CoV-1" exact="infection" post="in humans was first reported in 2002 in China"/>
  <result pre="meat, milk or urine, as shown in Figure 2. Human-to-human" exact="infection" post="also occurred through nosocomial transmission.11 Symptoms of human SARS-CoV-1"/>
  <result pre="lineage C of the beta-CoVs.11 The first cases of human" exact="infection" post="by MERS-CoV were reported in Saudi Arabia in 2012."/>
  <result pre="the natural hosts of MERS-CoV (Figure 2), and a high" exact="prevalence" post="of MERS-CoV infections in dromedary camels (intermediate hosts) was"/>
  <result pre="contact, good personal hygiene, personal protective equipment, sheltering at home," exact="isolation" post="of identified cases Other human coronaviruses Other important human"/>
  <result pre="the most common diagnostic tools for human CoVs are molecular" exact="detection" post="techniques such as reverse transcription-polymerase chain reaction (RTâ€�PCR) using"/>
  <result pre="the Ro value (Figure 7b). If R0â€‰ oâ€‰=â€‰1, each existing" exact="infection" post="causes one new infection. The disease will remain stable"/>
  <result pre="will not result in epidemic spread. If R0â€‰&amp;gt;â€‰1, each existing" exact="infection" post="causes more than one new infection. The disease will"/>
  <result pre="for about 3 hours, long enough to permit transmission. Upon" exact="infection" post="with SARS-CoV-2, the virus infects type II pneumocytes of"/>
  <result pre="linked to ocular signs and symptoms including photophobia, irritation, conjunctival" exact="infection" post="and ocular discharge.66 Thus, the superficial blood vessels of"/>
  <result pre="from flu and pneumonia is a nasopharyngeal swab test (viral" exact="testing" post="for influenza A/B).77 Quantitative polymerase chain reaction-based (qPCR) methods"/>
  <result pre="variable sensitivity (30%â€&quot;80%).78â€&quot;80 Another diagnostic method is the newly approved" exact="nucleic acid test," post="which is carried out based on the principle of"/>
  <result pre="the principle of fluorescence PCR.81 The main goal of SARS-CoV-2" exact="diagnosis" post="is to accurately detect the virus and to minimize"/>
  <result pre="detect the virus and to minimize further transmissions by timely" exact="isolation" post="and treatment of infected patients. Other tests (not specific"/>
  <result pre="virus and to minimize further transmissions by timely isolation and" exact="treatment" post="of infected patients. Other tests (not specific for SARS-CoV-2)"/>
  <result pre="diseases, (e) immunosuppression (e,g., cancer patients), and (f) diabetes. Potential" exact="treatment" post="of COVID-19 The first line of treatment for patients"/>
  <result pre="(f) diabetes. Potential treatment of COVID-19 The first line of" exact="treatment" post="for patients presented with the symptoms of COVID-19 (fever,"/>
  <result pre="is advisable to consult a clinician for confirmation of the" exact="diagnosis" post="and to avoid further spread of the virus. The"/>
  <result pre="and to avoid further spread of the virus. The main" exact="treatment" post="currently available is supportive care. Although there is limited"/>
  <result pre="remdesivir, chloroquine, ritonavir, tocilizumab, corticosteroids have been repurposed for the" exact="treatment" post="of COVID-19 (Figure 11), although their clinical effectiveness has"/>
  <result pre="suspended by the WHO.94 Figure 11. Selected repurposed drugs for" exact="treatment" post="of COVID-19. Mechanism of action of selected repurposed drugs"/>
  <result pre="of COVID-19. Mechanism of action of selected repurposed drugs for" exact="treatment" post="of COVID-19 The elucidation of potential targets could lead"/>
  <result pre="The protein inhibitor ritonavir has also been proposed for the" exact="treatment" post="of COVID-19. This drug interferes with the protease enzymes"/>
  <result pre="the host during infection. ACE-2, a potential target for COVID-19" exact="treatment" post="ACE-2 has been identified as the functional receptor for"/>
  <result pre="player in the renin-angiotensin system (RAS) and a target for" exact="treatment" post="of hypertension.105 ACE-2 catalyzes the cleavage of angiotensin II,"/>
  <result pre="RAS.106 ACE-2 is a promising drug target for treating CoV" exact="infection" post="as well as other cardiovascular diseases.5 ACE-2 confers a"/>
  <result pre="that the expression of human ACE-2 is associated with SARSâ€�CoV" exact="infection" post="and that genetic variations of this receptor may contribute"/>
  <result pre="and urgent goal. To prevent further spread of this disease," exact="detection" post="and isolation of individuals with COVID-19 is of the"/>
  <result pre="goal. To prevent further spread of this disease, detection and" exact="isolation" post="of individuals with COVID-19 is of the utmost priority."/>
  <result pre="utmost priority. Examples of measures to curb spread include self-quarantine," exact="isolation" post="of infected individuals, social distancing, good personal hygiene (frequent"/>
  <result pre="measures to curb spread include self-quarantine, isolation of infected individuals," exact="social distancing," post="good personal hygiene (frequent hand washing with soap and"/>
  <result pre="ranges. Key insights into the prevalence, pathophysiology, diagnosis, and potential" exact="treatment" post="of SARS-CoV-2 are herein summarized. Research efforts are being"/>
  <result pre="advisable that good hygiene practices including washing of hands and" exact="social distancing" post="should be practiced, and government guidance/guidelines should be followed."/>
  <result pre="92: 476â€&quot;478.32056235 40GuanWJNiZYHuY, et al.Clinical characteristics of 2019 novel coronavirus" exact="infection" post="in China. MedRxiv2020. 41YangJZhengYGouX, et al.Prevalence of comorbidities and"/>
  <result pre="20: 553â€&quot;558.32171059 48HellewellJAbbottSGimmaA, et al.Feasibility of controlling COVID-19 outbreaks by" exact="isolation" post="of cases and contacts. Lancet Glob Health2020; 8: e488â€&quot;e4968.32119825"/>
  <result pre="et al.Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: A retrospective review of medical"/>
  <result pre="379. 79BhadraSJiangYSKumarMR, et al.Real-time sequence-validated loop-mediated isothermal amplification assays for" exact="detection" post="of Middle East respiratory syndrome coronavirus (MERS-CoV). PLoS One2015;"/>
  <result pre="et al.Selective depletion of regulatory T cell subsets by docetaxel" exact="treatment" post="in patients with non-small cell lung cancer. J Immunol"/>
  <result pre="16, 2020. MMWR Morb Mortal Wkly Rep2020; 69: 343â€&quot;346.32214079 88LuH.Drug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV).Biosci Trends2020; 14: 69â€&quot;71.31996494"/>
  <result pre="Agents2020; 55: 105923.32070753 93KapoorKMKapoorA.Role of chloroquine and hydroxychloroquine in the" exact="treatment" post="of COVID-19 infection â€&quot; a systematic literature review. medRxiv2020."/>
  <result pre="93KapoorKMKapoorA.Role of chloroquine and hydroxychloroquine in the treatment of COVID-19" exact="infection" post="â€&quot; a systematic literature review. medRxiv2020. 94MehraMRDesaiSSRuschitzkaF, et al.Hydroxychloroquine"/>
  <result pre="et al.Hydroxychloroquine or chloroquine with or without a macrolide for" exact="treatment" post="of COVID-19: a multinational registry analysis.Lancet2020. 95LiCZhuXJiX, et al.Chloroquine,"/>
  <result pre="analysis.Lancet2020. 95LiCZhuXJiX, et al.Chloroquine, a FDA-approved drug, prevents Zika virus" exact="infection" post="and its associated congenital microcephaly in mice.EBioMedicine2017; 24: 189â€&quot;194.29033372"/>
  <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin"/>
 </snippets>
</snippetsTree>
